Find clinical trials for Acute Myeloid Leukemia (AML) in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Houston, TX, USA:
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
Huston, Texas, United States and 33 other locations
(R/R), measurable residual disease (MRD) positive acute myeloid leukemia (AML), or TP53mut disease....
Phase 1
Houston, Texas, United States and 4 other locations
CLN-049-001 is a Phase 1/2, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...
Phase 1, Phase 2
Houston, Texas, United States and 16 other locations
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Houston, Texas, United States and 23 other locations
People with acute myeloid leukemia (AML) are usually treated with chemotherapy. Some people with AML hav...
Phase 1, Phase 2
Houston, Texas, United States and 17 other locations
Antisense Oligodeoxynucleotide) in patients with refractory/relapsed AML. The study is designed to assess the safety profile, identify DLTs,...
Phase 1
Houston, Texas, United States and 3 other locations
PK of APG-2575 in combination with Azacitidine in the patients with AML/MPAL or MDS/CMML. The study consists of dose escalation (Part I) and...
Phase 1, Phase 2
Houston, Texas, United States and 8 other locations
treatment option for participants with blood cancers such as Acute Myeloid Leukemia (AML) which have a particular...
Phase 1
Houston, Texas, United States and 1 other location
This Phase 1, multicenter, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (...
Phase 1
Houston, Texas, United States and 8 other locations
The purpose of this study is to determine the recommended Phase 2 dose (RP2D) candidate(s) of bleximenib in combination with AML directed th...
Phase 1
Houston, Texas, United States and 33 other locations
Clinical trials
Research sites
Resources
Legal